CLINICAL_TRIALS
trial_result
· 2014-06-05
Clinical Trial Update: Study of SPM 962 in Patients With Restless Legs Syndrome (RLS) [Phase 3]
Summary
A Phase 3 clinical trial evaluating SPM 962 for idiopathic restless legs syndrome has completed, with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Idiopathic Restless Legs Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2014-06-05